The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Liraglutide Market Outlook 2025

Global Liraglutide Market Outlook 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1661850

No of Pages : 109

Synopsis
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

The global Liraglutide market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Liraglutide volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Liraglutide market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Liraglutide Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Pills
Liquid

Segment by Application
Hospital
Drug Store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Index
1 Liraglutide Market Overview
1.1 Product Overview and Scope of Liraglutide
1.2 Liraglutide Segment by Type
1.2.1 Global Liraglutide Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Pills
1.2.3 Liquid
1.3 Liraglutide Segment by Application
1.3.1 Global Liraglutide Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Liraglutide Market Size Estimates and Forecasts
1.4.1 Global Liraglutide Revenue 2016-2027
1.4.2 Global Liraglutide Sales 2016-2027
1.4.3 Liraglutide Market Size by Region: 2016 Versus 2021 Versus 2027

2 Liraglutide Market Competition by Manufacturers
2.1 Global Liraglutide Sales Market Share by Manufacturers (2016-2021)
2.2 Global Liraglutide Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Liraglutide Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Liraglutide Manufacturing Sites, Area Served, Product Type
2.5 Liraglutide Market Competitive Situation and Trends
2.5.1 Liraglutide Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Liraglutide Players Market Share by Revenue
2.5.3 Global Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Liraglutide Retrospective Market Scenario by Region
3.1 Global Liraglutide Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Liraglutide Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Liraglutide Market Facts & Figures by Country
3.3.1 North America Liraglutide Sales by Country
3.3.2 North America Liraglutide Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Liraglutide Market Facts & Figures by Country
3.4.1 Europe Liraglutide Sales by Country
3.4.2 Europe Liraglutide Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Liraglutide Market Facts & Figures by Region
3.5.1 Asia Pacific Liraglutide Sales by Region
3.5.2 Asia Pacific Liraglutide Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Liraglutide Market Facts & Figures by Country
3.6.1 Latin America Liraglutide Sales by Country
3.6.2 Latin America Liraglutide Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Liraglutide Market Facts & Figures by Country
3.7.1 Middle East and Africa Liraglutide Sales by Country
3.7.2 Middle East and Africa Liraglutide Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Liraglutide Historic Market Analysis by Type
4.1 Global Liraglutide Sales Market Share by Type (2016-2021)
4.2 Global Liraglutide Revenue Market Share by Type (2016-2021)
4.3 Global Liraglutide Price by Type (2016-2021)

5 Global Liraglutide Historic Market Analysis by Application
5.1 Global Liraglutide Sales Market Share by Application (2016-2021)
5.2 Global Liraglutide Revenue Market Share by Application (2016-2021)
5.3 Global Liraglutide Price by Application (2016-2021)

6 Key Companies Profiled
6.1 HEC Pharm
6.1.1 HEC Pharm Corporation Information
6.1.2 HEC Pharm Description and Business Overview
6.1.3 HEC Pharm Liraglutide Sales, Revenue and Gross Margin (2016-2021)
6.1.4 HEC Pharm Liraglutide Product Portfolio
6.1.5 HEC Pharm Recent Developments/Updates
6.2 Bachem
6.2.1 Bachem Corporation Information
6.2.2 Bachem Description and Business Overview
6.2.3 Bachem Liraglutide Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bachem Liraglutide Product Portfolio
6.2.5 Bachem Recent Developments/Updates
6.3 Bharat Pharmaceuticals
6.3.1 Bharat Pharmaceuticals Corporation Information
6.3.2 Bharat Pharmaceuticals Description and Business Overview
6.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bharat Pharmaceuticals Liraglutide Product Portfolio
6.3.5 Bharat Pharmaceuticals Recent Developments/Updates
6.4 Kingpep Biotechnology
6.4.1 Kingpep Biotechnology Corporation Information
6.4.2 Kingpep Biotechnology Description and Business Overview
6.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Kingpep Biotechnology Liraglutide Product Portfolio
6.4.5 Kingpep Biotechnology Recent Developments/Updates
6.5 Shenzhen JYMed Technology
6.5.1 Shenzhen JYMed Technology Corporation Information
6.5.2 Shenzhen JYMed Technology Description and Business Overview
6.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Shenzhen JYMed Technology Liraglutide Product Portfolio
6.5.5 Shenzhen JYMed Technology Recent Developments/Updates
6.6 Wuxi Asiapeptide
6.6.1 Wuxi Asiapeptide Corporation Information
6.6.2 Wuxi Asiapeptide Description and Business Overview
6.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Wuxi Asiapeptide Liraglutide Product Portfolio
6.6.5 Wuxi Asiapeptide Recent Developments/Updates
6.7 AmbioPharm
6.6.1 AmbioPharm Corporation Information
6.6.2 AmbioPharm Description and Business Overview
6.6.3 AmbioPharm Liraglutide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 AmbioPharm Liraglutide Product Portfolio
6.7.5 AmbioPharm Recent Developments/Updates

7 Liraglutide Manufacturing Cost Analysis
7.1 Liraglutide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Liraglutide
7.4 Liraglutide Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Liraglutide Distributors List
8.3 Liraglutide Customers

9 Liraglutide Market Dynamics
9.1 Liraglutide Industry Trends
9.2 Liraglutide Growth Drivers
9.3 Liraglutide Market Challenges
9.4 Liraglutide Market Restraints

10 Global Market Forecast
10.1 Liraglutide Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Liraglutide by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Liraglutide by Type (2022-2027)
10.2 Liraglutide Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Liraglutide by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Liraglutide by Application (2022-2027)
10.3 Liraglutide Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Liraglutide by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Liraglutide by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Liraglutide Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Liraglutide Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Liraglutide Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Liraglutide Covered in This Study
Table 5. Global Liraglutide Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Liraglutide Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Liraglutide Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Liraglutide Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Liraglutide Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Liraglutide Manufacturing Sites and Area Served
Table 11. Manufacturers Liraglutide Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Liraglutide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Liraglutide Sales by Region (2016-2021) & (K MT)
Table 16. Global Liraglutide Sales Market Share by Region (2016-2021)
Table 17. Global Liraglutide Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Liraglutide Sales by Country (2016-2021) & (K MT)
Table 19. North America Liraglutide Sales Market Share by Country (2016-2021)
Table 20. North America Liraglutide Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Liraglutide Revenue Market Share by Country (2016-2021)
Table 22. Europe Liraglutide Sales by Country (2016-2021) & (K MT)
Table 23. Europe Liraglutide Sales Market Share by Country (2016-2021)
Table 24. Europe Liraglutide Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Liraglutide Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Liraglutide Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Liraglutide Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Liraglutide Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Liraglutide Revenue Market Share by Region (2016-2021)
Table 30. Latin America Liraglutide Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Liraglutide Sales Market Share by Country (2016-2021)
Table 32. Latin America Liraglutide Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Liraglutide Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Liraglutide Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Liraglutide Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Liraglutide Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Liraglutide Revenue Market Share by Country (2016-2021)
Table 38. Global Liraglutide Sales (K MT) by Type (2016-2021)
Table 39. Global Liraglutide Sales Market Share by Type (2016-2021)
Table 40. Global Liraglutide Revenue (Million US$) by Type (2016-2021)
Table 41. Global Liraglutide Revenue Share by Type (2016-2021)
Table 42. Global Liraglutide Price (USD/MT) by Type (2016-2021)
Table 43. Global Liraglutide Sales (K MT) by Application (2016-2021)
Table 44. Global Liraglutide Sales Market Share by Application (2016-2021)
Table 45. Global Liraglutide Revenue (Million US$) by Application (2016-2021)
Table 46. Global Liraglutide Revenue Share by Application (2016-2021)
Table 47. Global Liraglutide Price (USD/MT) by Application (2016-2021)
Table 48. HEC Pharm Corporation Information
Table 49. HEC Pharm Description and Business Overview
Table 50. HEC Pharm Liraglutide Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. HEC Pharm Liraglutide Product
Table 52. HEC Pharm Recent Developments/Updates
Table 53. Bachem Corporation Information
Table 54. Bachem Description and Business Overview
Table 55. Bachem Liraglutide Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Bachem Liraglutide Product
Table 57. Bachem Recent Developments/Updates
Table 58. Bharat Pharmaceuticals Corporation Information
Table 59. Bharat Pharmaceuticals Description and Business Overview
Table 60. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Bharat Pharmaceuticals Liraglutide Product
Table 62. Bharat Pharmaceuticals Recent Developments/Updates
Table 63. Kingpep Biotechnology Corporation Information
Table 64. Kingpep Biotechnology Description and Business Overview
Table 65. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Kingpep Biotechnology Liraglutide Product
Table 67. Kingpep Biotechnology Recent Developments/Updates
Table 68. Shenzhen JYMed Technology Corporation Information
Table 69. Shenzhen JYMed Technology Description and Business Overview
Table 70. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Shenzhen JYMed Technology Liraglutide Product
Table 72. Shenzhen JYMed Technology Recent Developments/Updates
Table 73. Wuxi Asiapeptide Corporation Information
Table 74. Wuxi Asiapeptide Description and Business Overview
Table 75. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Wuxi Asiapeptide Liraglutide Product
Table 77. Wuxi Asiapeptide Recent Developments/Updates
Table 78. AmbioPharm Corporation Information
Table 79. AmbioPharm Description and Business Overview
Table 80. AmbioPharm Liraglutide Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. AmbioPharm Liraglutide Product
Table 82. AmbioPharm Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Liraglutide Distributors List
Table 86. Liraglutide Customers List
Table 87. Liraglutide Market Trends
Table 88. Liraglutide Growth Drivers
Table 89. Liraglutide Market Challenges
Table 90. Liraglutide Market Restraints
Table 91. Global Liraglutide Sales Forecast by Type (2022-2027) & (K MT)
Table 92. Global Liraglutide Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Liraglutide Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Liraglutide Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Liraglutide Sales Forecast by Application (2022-2027) & (K MT)
Table 96. Global Liraglutide Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Liraglutide Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Liraglutide Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Liraglutide Sales Forecast by Region (2022-2027) & (K MT)
Table 100. Global Liraglutide Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Liraglutide Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Liraglutide Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Liraglutide
Figure 2. Global Liraglutide Market Share by Type in 2020 & 2027
Figure 3. Pills Product Picture
Figure 4. Liquid Product Picture
Figure 5. Global Liraglutide Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Global Liraglutide Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Liraglutide Market Size 2016-2027 (US$ Million)
Figure 10. Global Liraglutide Sales 2016-2027 (K MT)
Figure 11. Global Liraglutide Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Liraglutide Sales Share by Manufacturers in 2020
Figure 13. Global Liraglutide Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Liraglutide Players: Market Share by Revenue in 2020
Figure 15. Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Liraglutide Sales Market Share by Region (2016-2021)
Figure 17. Global Liraglutide Sales Market Share by Region in 2020
Figure 18. Global Liraglutide Revenue Market Share by Region (2016-2021)
Figure 19. Global Liraglutide Revenue Market Share by Region in 2020
Figure 20. U.S. Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Taiwan Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Mexico Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Brazil Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Argentina Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Turkey Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Saudi Arabia Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. UAE Liraglutide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Sales Market Share of Liraglutide by Type (2016-2021)
Figure 43. Sales Market Share of Liraglutide by Application (2016-2021)
Figure 44. Sales Market Share of Liraglutide by Application in 2020
Figure 45. Revenue Share of Liraglutide by Application (2016-2021)
Figure 46. Revenue Share of Liraglutide by Application in 2020
Figure 47. Manufacturing Cost Structure of Liraglutide
Figure 48. Manufacturing Process Analysis of Liraglutide
Figure 49. Liraglutide Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’